← Back to Search

Trauma Control Subjects for Post-Traumatic Stress Disorder

Q: Does the trial cohort include elderly individuals?

This medical trial is recruiting individuals aged between 30 and 65 years old.

Q: What is the maximum capacity for enrollees in this clinical study?

Affirmative. As per the information on clinicaltrials.gov, this medical investigation is actively recruiting patients at present. This trial was initially published on November 28th 2017 and had its details revised most recently on August 29th 2022. The study seeks to enrol 240 people between 2 different sites.

Q: Are there any spots still available to join this clinical experiment?

Affirmative, clinicaltrials.gov's data indicates that this study is actively recruiting participants. It was posted on 28th November 2017 and last updated 29th August 2022; 240 patients are required between two sites for the trial to be completed.

Q: Who has the opportunity to participate in this research project?

To be eligible for this study, individuals needs to have atherogenesis and must lie between the age brackets of 30 and 65. This clinical trial aims to recruit a total of 240 patients.

Phase < 1

Waitlist Available

Led By Zahi Fayad, PhD

Research Sponsored by Zahi Fayad

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1

Awards & highlights

Study Summary

This trial looks at the connection between stress and heart disease. They will be studying how stress affects the brain and how that relates to inflammation and atherosclerosis.

Eligible Conditions

Post Traumatic Stress Disorder
Trauma
Healthy Subjects

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Atherosclerotic burden in PTSD using PET/MRI

Secondary outcome measures

Degree of brain fear circuit activation

Level of circulating HPSCs

Level of circulating immune cells

+1 more

Trial Design

3Treatment groups

Active Control

Placebo Group

Group I: Trauma Control SubjectsActive Control1 Intervention

Group II: PTSD SubjectsActive Control1 Intervention

Group III: Healthy Control SubjectsPlacebo Group1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,836 Previous Clinical Trials

47,850,667 Total Patients Enrolled

Massachusetts General HospitalOTHER

2,932 Previous Clinical Trials

13,198,300 Total Patients Enrolled

Zahi FayadLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the trial cohort include elderly individuals?

"This medical trial is recruiting individuals aged between 30 and 65 years old."

Answered by AI

What is the maximum capacity for enrollees in this clinical study?

"Affirmative. As per the information on clinicaltrials.gov, this medical investigation is actively recruiting patients at present. This trial was initially published on November 28th 2017 and had its details revised most recently on August 29th 2022. The study seeks to enrol 240 people between 2 different sites."

Answered by AI

Are there any spots still available to join this clinical experiment?

"Affirmative, clinicaltrials.gov's data indicates that this study is actively recruiting participants. It was posted on 28th November 2017 and last updated 29th August 2022; 240 patients are required between two sites for the trial to be completed."

Answered by AI

Who has the opportunity to participate in this research project?

"To be eligible for this study, individuals needs to have atherogenesis and must lie between the age brackets of 30 and 65. This clinical trial aims to recruit a total of 240 patients."

Answered by AI